Comparative molecular characterization of typical and exceptional responders in glioblastoma
Sign Up to like & getrecommendations! Published in 2018 at "Oncotarget"
DOI: 10.18632/oncotarget.25420
Abstract: Glioblastoma (GBM) is the most common and the deadliest type of primary brain tumor, with a median survival time of only 15 months despite aggressive treatment. Although most patients have an extremely poor prognosis, a… read more here.
Keywords: molecular characterization; comparative molecular; exceptional responders; responders glioblastoma ... See more keywords